Is there a gene that is associated with uveitis, axial spondyloarthritis (axSpA), and Crohn's disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Genetic Correlation Between Uveitis, Axial Spondyloarthritis, and Crohn's Disease

Yes, multiple genes are shared across all three conditions, with IL23R being the most prominent genetic link connecting uveitis, axial spondyloarthritis, and Crohn's disease. 1

Shared Genetic Loci

The strongest evidence comes from genome-wide association studies demonstrating substantial genetic overlap between these conditions:

IL-23 Pathway Genes

Eight of 11 identified genetic loci for ankylosing spondylitis are shared with inflammatory bowel disease (including Crohn's disease), representing a 13-fold enrichment above expected levels. 1 The shared genes include:

  • IL23R - Most consistently associated across all three conditions 1, 2
  • IL12B - Linked to the TH17 inflammatory pathway 1
  • STAT3 - Part of the TH17 pathway 1
  • PTGER4 - Connected to TH17 responses 1

Additional Shared Genetic Factors

  • CARD9 - Linked to the NFκB pathway, shared between axial spondyloarthritis and Crohn's disease 1
  • ILR2 and ORMDDL3 - Associated with immune responses across these conditions 1

HLA-B27 Association

HLA-B27 is strongly associated with both axial spondyloarthritis and uveitis, though its role in Crohn's disease is less direct. 1, 3, 4

  • In axial spondyloarthritis with IBD: HLA-B27 prevalence is approximately 70% 1
  • In acute anterior uveitis: HLA-B27 is strongly positive 3, 4
  • However, HLA-B27 has lower prevalence in IBD-associated axial disease compared to idiopathic ankylosing spondylitis (≈70% vs 94%), making it unreliable as a diagnostic test in the IBD setting 1

Clinical Significance

The genetic overlap explains why up to 20% of IBD patients develop sacroiliitis and spondylitis, and why up to 70% of patients with ankylosing spondylitis have microscopic gut inflammation. 1 This shared genetic architecture extends beyond the major histocompatibility complex and involves key immune pathways, particularly the TH17 network. 1

Important Caveats

  • The IL-23R association shows ethnic variation - it is seen primarily in Caucasians but not consistently in Asian populations 2
  • While these genetic associations are scientifically robust, individual genetic variants have effect sizes too small for diagnostic or prognostic use in clinical practice 5
  • The pathogenesis involves complex interactions between genetic predisposition, environmental factors, and immune dysregulation 6, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The genetic basis of spondyloarthritis.

Annals of the rheumatic diseases, 2011

Research

Genetics and the axial spondyloarthritis spectrum.

Rheumatology (Oxford, England), 2020

Research

The Genetics of Spondyloarthritis.

Journal of personalized medicine, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.